Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum lipids and higher fatty acids were investigated in 141 patients with portal
liver cirrhosis
, 51 patients with chronic hepatitis and 40 clinically healthy subjects--controls. Lower contents of cholesterin in blood was found in the patients with
liver cirrhosis
as compared with the healthy as well as of total lipids, phospholipids, beta-LP, palmitic, palmitoleic, oleic linoleic and linolenic acids and considerably higher contents, of NEFA endogene heparin,
LPL
and blood sugar. The deviations described are more manifested in decompensated
liver cirrhosis
. In the patients with chronic hepatitis, as compared with the controls higher contents of cholesterin, total lipids, phospholipids, triglyceride, beta-LP, NEFA,
LPL
, endogene heparin, stearinic, palmitic, palmitoleic and oleic acids and blood sugar were found. In the patients with
liver cirrhosis
, as compared with the patients with chronic hepatitis, a lower contents of cholesterin was found as well as of total lipids, phospholipids, triglycerides, beta-LP, palmitic, palmitoleic and oleic acids and a higher contents of and blood sugar. The described deviations in the contents of serum lipid indices are with a definite regular character and can be used in the diagnosis of liver diseases.
...
PMID:[Deviations in the level of serum lipids and higher fatty acids in liver cirrhosis and chronic hepatitis]. 87 49